US2012071485A1PendingUtilityA1
Therapeutic Compositions And Methods
Est. expiryMay 12, 2025(expired)· nominal 20-yr term from priority
Inventors:George C. Y. Chiou
A61P 43/00A61P 27/06A61K 31/55A61P 27/02
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates in general to therapeutic compositions and methods of use. In preferred embodiments, the invention relates to the field of eye health. In some embodiments, the invention relates to the prevention and treatment of macular degeneration by administering compounds disclosed herein. In some embodiments, the invention relates to compositions and methods of improving vision.
Claims
exact text as granted — not AI-modified1 . A method of treating macular degeneration comprising:
1) providing:
i) a subject diagnosed with macular degeneration and
ii) a composition comprising tetramethylpyrazine or salt thereof and
2) administering said compound to said subject.
2 . The method of claim 1 , wherein said macular degeneration is age-related.
3 . The method of claim 1 , wherein said subject is a human.
4 . The method of claim 1 , wherein said administration is topically to the eye.
5 . The method of claim 1 , wherein said salt is a hydrochloride salt.
6 . The method of claim 1 , wherein said composition is a liquid solution.
7 . A method of treating macular degeneration comprising:
1) providing
i) a subject diagnosed with macular degeneration and
ii) a composition comprising a substituted or unsubstituted compound of the following formula:
or salt thereof functioning to decrease choroidal neovascularization and
2) administering said compound to said subject.
8 - 21 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.